112 results
Page 3 of 6
8-K
EX-10.1
hh3uoaa
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-2.1
6xgudykuo
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
424B5
588dxw1 1owds4qknv9
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-10.2
3wl2jp2pgrgyu2v gh
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
8igydo8aia 9g2h2
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
28cuk
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
8-K
EX-99.1
ezya8 o8adqk00r5zu6
27 May 21
Regulation FD Disclosure
7:01am
8-K
EX-10.3
svm0kec3s
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
kpljlub3tl ycjid
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am